美国联邦食品和药物管理局(FDA)日前批准了第一种治疗中度与重度老年性痴呆的药物美金刚胺(meman-tine)。据美国《世界日报》报道,美金刚胺可以抑制大脑内部过多的谷氨酸盐,这种物质可伤害或杀死神经细胞。经证实,美金刚胺可使老年痴呆症的恶化速度减缓,让患者自行上厕所等行动维持的时间延长。 The U.S. Federal Food and Drug Administration (FDA) recently approved the first meman-tine drug to treat moderate and severe dementia. According to the United States, “World News” reported that memantine can inhibit excessive glutamate inside the brain, this substance can injure or kill nerve cells. It has been confirmed that memantine can slow down the deterioration of Alzheimer’s disease and prolong the duration of the patient’s own activities such as going to the toilet.